| Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
  | acute myeloid leukemia | ASXL1* | Asxl1* | 1 model | Alliance of Genome Resources | ||
| acute myeloid leukemia | CEBPA* | Cebpa* | 1 model | Alliance of Genome Resources | |||
| acute myeloid leukemia | CREBBP* | Crebbp* | 1 model | Alliance of Genome Resources | |||
| acute myeloid leukemia | FLT3* | Flt3* | 4 models | Alliance of Genome Resources | |||
| acute myeloid leukemia | KMT2A* | Kmt2a* | 4 models | Alliance of Genome Resources | |||
| B-cell lymphoma | EZH2* | Ezh2* | 1 model | Alliance of Genome Resources | |||
| Burkitt lymphoma | MYC* | Myc* | 4 models | Alliance of Genome Resources | |||
| essential thrombocythemia | JAK2* | Jak2* | 2 models | Alliance of Genome Resources | |||
| juvenile myelomonocytic leukemia | PTPN11* | Ptpn11* | 1 model | Alliance of Genome Resources | |||
| juvenile myelomonocytic leukemia | NF1* | Nf1* | 2 models | Alliance of Genome Resources | |||
| myelodysplastic syndrome | ASXL1* | Asxl1* | 5 models | Alliance of Genome Resources | |||
| myelodysplastic syndrome | SF3B1* | Sf3b1* | 2 models | Alliance of Genome Resources | |||
| myelodysplastic syndrome | SRSF2* | Srsf2* | 1 model | Alliance of Genome Resources | |||
| myelofibrosis | JAK2* | Jak2* | 2 models | Alliance of Genome Resources | |||
| myeloproliferative neoplasm | PDGFRB* | Pdgfrb* | 1 model | Alliance of Genome Resources | |||
| polycythemia vera | JAK2* | Jak2* | 6 models | Alliance of Genome Resources | |||
| | acute lymphoblastic leukemia | EZH2 | Ezh2* | 2 models | Alliance of Genome Resources | ||
| acute lymphoblastic leukemia | KMT2A | Kmt2a* | 1 model | Alliance of Genome Resources | |||
| acute lymphoblastic leukemia | LMO2 | Lmo2* | 1 model | Alliance of Genome Resources | |||
| acute lymphoblastic leukemia | NOTCH3 | Notch3* | 1 model | Alliance of Genome Resources | |||
| acute lymphoblastic leukemia | PTEN | Pten* | 1 model | Alliance of Genome Resources | |||
| acute myeloid leukemia | ARID4A | Arid4a* | 2 models | Alliance of Genome Resources | |||
| acute myeloid leukemia | MYBL2 | Mybl2* | 1 model | Alliance of Genome Resources | |||
| acute myeloid leukemia | SPI1 | Spi1* | 1 model | Alliance of Genome Resources | |||
| chronic myeloid leukemia | CHORDC1 | Chordc1* | 1 model | Alliance of Genome Resources | |||
| chronic myeloid leukemia | NCSTN | Ncstn* | 2 models | Alliance of Genome Resources | |||
| chronic myeloid leukemia | SH2B3 | Sh2b3* | 1 model | Alliance of Genome Resources | |||
| chronic myeloid leukemia | SIPA1 | Sipa1* | 2 models | Alliance of Genome Resources | |||
| chronic myelomonocytic leukemia | KDM6A | Kdm6a* | 2 models | Alliance of Genome Resources | |||
| diffuse large B-cell lymphoma | TP53 | Trp53* | 2 models | Alliance of Genome Resources | |||
| diffuse large B-cell lymphoma | SMURF2 | Smurf2* | 1 model | Alliance of Genome Resources | |||
| essential thrombocythemia | MYB | Myb* | 1 model | Alliance of Genome Resources | |||
| familial chronic myelocytic leukemia-like syndrome | IRF8 | Irf8* | 4 models | Alliance of Genome Resources | |||
| follicular lymphoma | RARRES1 | Rarres1* | 3 models | Alliance of Genome Resources | |||
| juvenile myelomonocytic leukemia | KRAS | Kras* | 3 models | Alliance of Genome Resources | |||
| juvenile myelomonocytic leukemia | FLT3 | Flt3* | 2 models | Alliance of Genome Resources | |||
| lymphoid leukemia | TAL1 | Tal1* | 1 model | Alliance of Genome Resources | |||
| lymphoma | HMGA1 | Hmga1*, Hmga1b | 1 model | Alliance of Genome Resources | |||
| lymphoma | MIR155 | Mir155* | 1 model | Alliance of Genome Resources | |||
| multiple myeloma | MAF | Maf* | 2 models | Alliance of Genome Resources | |||
| myelodysplastic/myeloproliferative neoplasm | DIDO1 | Dido1* | 1 model | Alliance of Genome Resources | |||
| myelodysplastic syndrome | MACROH2A1 | Macroh2a1* | 1 model | Alliance of Genome Resources | |||
| myelodysplastic syndrome | SAMD9L | Samd9l* | 1 model | Alliance of Genome Resources | |||
| myelodysplastic syndrome | POLG | Polg* | 1 model | Alliance of Genome Resources | |||
| myelodysplastic syndrome | NPM1 | Npm1* | 1 model | Alliance of Genome Resources | |||
| myelodysplastic syndrome | MYBL2 | Mybl2* | 1 model | Alliance of Genome Resources | |||
| myelodysplastic syndrome | GATA1 | Gata1* | 1 model | Alliance of Genome Resources | |||
| myelodysplastic syndrome | EGR1 | Egr1* | 1 model | Alliance of Genome Resources | |||
| myelodysplastic syndrome | CREBBP | Crebbp* | 1 model | Alliance of Genome Resources | |||
| myelodysplastic syndrome | BAP1 | Bap1* | 1 model | Alliance of Genome Resources | |||
| myelodysplastic syndrome | ATG7 | Atg7* | 1 model | Alliance of Genome Resources | |||
| myelofibrosis | NCOR2 | Ncor2* | 1 model | Alliance of Genome Resources | |||
| myelofibrosis | MYB | Myb* | 1 model | Alliance of Genome Resources | |||
| myelofibrosis | GATA1 | Gata1* | 2 models | Alliance of Genome Resources | |||
| myeloproliferative neoplasm | ASXL1 | Asxl1* | 1 model | Alliance of Genome Resources | |||
| myeloproliferative neoplasm | JAK2 | Jak2* | 1 model | Alliance of Genome Resources | |||
| non-Hodgkin lymphoma | S1PR2 | S1pr2* | 2 models | Alliance of Genome Resources | |||
| non-Hodgkin lymphoma | MTSS1 | Mtss1* | 1 model | Alliance of Genome Resources | |||
| peripheral T-cell lymphoma | RC3H1 | Rc3h1* | 1 model | Alliance of Genome Resources | |||
| T-cell acute lymphoblastic leukemia | HMGA1 | Hmga1*, Hmga1b | 1 model | Alliance of Genome Resources | |||
| T-cell acute lymphoblastic leukemia | NBN | Nbn* | 1 model | Alliance of Genome Resources | |||
| T-cell adult acute lymphocytic leukemia | ZEB2 | Zeb2* | 2 models | Alliance of Genome Resources | |||
| T-cell adult acute lymphocytic leukemia | CNTN2 | Cntn2* | 1 model | Alliance of Genome Resources | |||
| | acute biphenotypic leukemia | DOT1L* | Dot1l | Alliance of Genome Resources | |||
| acute lymphoblastic leukemia | GNB1* | Gnb1 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | GH1*, CSH1, CSH2, CSHL1, GH2 | Gh | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | FLT3* | Flt3 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | ERCC1* | Ercc1 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | EPHX1* | Ephx1 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | DPYD* | Dpyd | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | DNMT3A* | Dnmt3a | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | DHFR*, DHFR2 | Dhfr | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | CYP3A5*, CYP3A4, CYP3A7, CYP3A7-CYP3A51P, CYP3A43 | Cyp3a11, Cyp3a13, Cyp3a16, Cyp3a25, Cyp3a41a, Cyp3a41b, Cyp3a44, Cyp3a57, Cyp3a59 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | CYP2D6*, CYP2D7 | Cyp2d9, Cyp2d10, Cyp2d11, Cyp2d12, Cyp2d22, Cyp2d26, Cyp2d34, Cyp2d40 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | GPX1* | Gpx1 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | H1-2* | H1f2 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | GSTP1* | Gstp1, Gstp2, Gstp3 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | ABCB1* | Abcb1a, Abcb1b | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | ABCC2* | Abcc2 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | ABO* | Abo | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | BAX* | Bax | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | BCL2L1* | Bcl2l1 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | TYMS* | Tyms | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | TTC12* | Ttc12 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | TPMT* | Tpmt | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | TERT* | Tert | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | TAL2* | Tal2 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | TAL1* | Tal1 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | PON1* | Pon1 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | PAX5* | Pax5 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | NUP214* | Nup214 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | NRAS* | Nras | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | NQO1* | Nqo1 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | NOS3* | Nos3 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | NBN* | Nbn | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | NAT2*, NAT1 | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | MTRR* | Mtrr | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | MTR* | Mtr | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | MEFV* | Mefv | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | KRAS* | Kras | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | KDM6A* | Kdm6a | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | ITPA* | Itpa | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | IRF4* | Irf4 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | IKZF1* | Ikzf1 | 1 model | Alliance of Genome Resources | |||
| acute lymphoblastic leukemia | IFNG* | Ifng | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | HK1* | Hk1 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | HFE* | Hfe | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | BCR* | Bcr | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | CDKN2A*, CDKN2B | Cdkn2a, Cdkn2b | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | CFB* | Cfb | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | CREBBP* | Crebbp | Alliance of Genome Resources | ||||
| acute lymphoblastic leukemia | CSF3* | Csf3 | Alliance of Genome Resources | ||||
| acute megakaryocytic leukemia | JAK3* | Jak3 | Alliance of Genome Resources | ||||
| acute megakaryocytic leukemia | EZH2* | Ezh2 | Alliance of Genome Resources | ||||
| acute megakaryocytic leukemia | MRTFA* | Mrtfa | Alliance of Genome Resources | ||||
| acute monocytic leukemia | MLLT10* | Mllt10 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | DNMT3A* | Dnmt3a | Alliance of Genome Resources | ||||
| acute myeloid leukemia | DLEC1* | Dlec1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | CYP2D6*, CYP2D7 | Cyp2d9, Cyp2d10, Cyp2d11, Cyp2d12, Cyp2d22, Cyp2d26, Cyp2d34, Cyp2d40 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | CYP2B6* | Cyp2b9, Cyp2b10, Cyp2b13, Cyp2b19, Cyp2b23 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | CXCR4* | Cxcr4 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | CSF3R* | Csf3r | Alliance of Genome Resources | ||||
| acute myeloid leukemia | CSF3* | Csf3 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | CSF2* | Csf2 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | CHIC2* | Chic2 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | CFHR1*, CFHR2 | Cfhr1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | CDKN2A*, CDKN2B* | Cdkn2a, Cdkn2b | Alliance of Genome Resources | ||||
| acute myeloid leukemia | CDKN1B* | Cdkn1b | Alliance of Genome Resources | ||||
| acute myeloid leukemia | CDH1* | Cdh1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | CCND1* | Ccnd1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | CBL* | Cbl | Alliance of Genome Resources | ||||
| acute myeloid leukemia | BRD7* | Brd7 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | BMI1*, COMMD3-BMI1 | Bmi1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | BCL2* | Bcl2 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | ACSL6* | Acsl6 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | ABL1* | Abl1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | ZRSR2*, ZRSR2P1 | Zrsr2, Zrsr2-ps1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
| acute myeloid leukemia | TYMS* | Tyms | Alliance of Genome Resources | ||||
| acute myeloid leukemia | TP53* | Trp53 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | TFPI2* | Tfpi2 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | TET2* | Tet2 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | TERT* | Tert | Alliance of Genome Resources | ||||
| acute myeloid leukemia | SRSF2* | Srsf2 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | SOD2* | Sod2 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | SOCS1* | Socs1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | SH3GL1* | Sh3gl1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | SAMHD1* | Samhd1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | RUNX1* | Runx1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | PICALM* | Picalm | Alliance of Genome Resources | ||||
| acute myeloid leukemia | PHF6* | Phf6 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | NUP214* | Nup214 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | NSD1* | Nsd1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | NRAS* | Nras | Alliance of Genome Resources | ||||
| acute myeloid leukemia | NQO1* | Nqo1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | NPM1* | Npm1 | 1 "NOT" model | Alliance of Genome Resources | |||
| acute myeloid leukemia | NOS3* | Nos3 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | NF1* | Nf1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | NCOA2* | Ncoa2 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | NAT2*, NAT1 | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | MTRR* | Mtrr | Alliance of Genome Resources | ||||
| acute myeloid leukemia | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| acute myeloid leukemia | MLLT10* | Mllt10 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | MEFV* | Mefv | Alliance of Genome Resources | ||||
| acute myeloid leukemia | LPP* | Lpp | Alliance of Genome Resources | ||||
| acute myeloid leukemia | KRAS* | Kras | 1 "NOT" model | Alliance of Genome Resources | |||
| acute myeloid leukemia | KIT* | Kit | Alliance of Genome Resources | ||||
| acute myeloid leukemia | KAT6A* | Kat6a | Alliance of Genome Resources | ||||
| acute myeloid leukemia | JAK2* | Jak2 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | ITGB3* | Itgb3 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | ITGAV* | Itgav | Alliance of Genome Resources | ||||
| acute myeloid leukemia | IL6* | Il6 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | IL1A* | Il1a | Alliance of Genome Resources | ||||
| acute myeloid leukemia | IDH2* | Idh2 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | IDH1* | Idh1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | GSTP1* | Gstp1, Gstp2, Gstp3 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | GPX1* | Gpx1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | GFI1* | Gfi1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | GATA2* | Gata2 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | FGFR1* | Fgfr1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | FAS* | Fas | Alliance of Genome Resources | ||||
| acute myeloid leukemia | FANCC* | Fancc | Alliance of Genome Resources | ||||
| acute myeloid leukemia | FANCA* | Fanca | Alliance of Genome Resources | ||||
| acute myeloid leukemia | EZH2* | Ezh2 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | ETV6* | Etv6 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | ERCC1* | Ercc1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | EPHX1* | Ephx1 | Alliance of Genome Resources | ||||
| acute myeloid leukemia | DNMT3B* | Dnmt3b | Alliance of Genome Resources | ||||
| acute myelomonocytic leukemia | ARHGAP26* | Arhgap26 | Alliance of Genome Resources | ||||
| acute myelomonocytic leukemia | GMPS* | Gmps | Alliance of Genome Resources | ||||
| acute myelomonocytic leukemia | FLT3* | Flt3 | Alliance of Genome Resources | ||||
| acute myelomonocytic leukemia | CBFB* | Cbfb | Alliance of Genome Resources | ||||
| acute promyelocytic leukemia | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| acute promyelocytic leukemia | MYC* | Myc | Alliance of Genome Resources | ||||
| acute promyelocytic leukemia | PML* | Pml | 1 model | Alliance of Genome Resources | |||
| acute promyelocytic leukemia | RARA* | Rara | Alliance of Genome Resources | ||||
| acute promyelocytic leukemia | ZBTB16* | Zbtb16 | 1 model | Alliance of Genome Resources | |||
| acute promyelocytic leukemia | CDKN2B*, CDKN2A | Cdkn2a, Cdkn2b | Alliance of Genome Resources | ||||
| adult T-cell leukemia/lymphoma | FAS* | Fas | Alliance of Genome Resources | ||||
| adult T-cell leukemia/lymphoma | JAK3* | Jak3 | Alliance of Genome Resources | ||||
| adult T-cell leukemia/lymphoma | NOTCH1* | Notch1 | Alliance of Genome Resources | ||||
| adult T-cell leukemia/lymphoma | TAL2* | Tal2 | Alliance of Genome Resources | ||||
| adult T-cell leukemia/lymphoma | TLX1* | Tlx1 | Alliance of Genome Resources | ||||
| anaplastic large cell lymphoma | IRF4* | Irf4 | Alliance of Genome Resources | ||||
| atypical chronic myeloid leukemia, BCR-ABL1 negative | FGFR1* | Fgfr1 | Alliance of Genome Resources | ||||
| B-cell lymphoma | BCL6* | Bcl6 | Alliance of Genome Resources | ||||
| B-cell lymphoma | ABCG2* | Abcg2, Abcg3 | Alliance of Genome Resources | ||||
| B-cell lymphoma | BRD2* | Brd2 | Alliance of Genome Resources | ||||
| B-cell lymphoma | BTK* | Btk | Alliance of Genome Resources | ||||
| B-cell lymphoma | CD40* | Cd40 | Alliance of Genome Resources | ||||
| B-cell lymphoma | IL21R* | Il21r | Alliance of Genome Resources | ||||
| B-lymphoblastic leukemia/lymphoma | AKR1C3*, AKR1C1, AKR1C2, AKR1C4 | Akr1c6, Akr1c12, Akr1c13, Akr1c14, Akr1c18, Akr1c19, Akr1c20, Akr1c21, Akr1cl | Alliance of Genome Resources | ||||
| B-lymphoblastic leukemia/lymphoma | BRD2* | Brd2 | Alliance of Genome Resources | ||||
| B-lymphoblastic leukemia/lymphoma | CDKN2A*, CDKN2B | Cdkn2a, Cdkn2b | Alliance of Genome Resources | ||||
| B-lymphoblastic leukemia/lymphoma | CYP3A5*, CYP3A4, CYP3A7, CYP3A7-CYP3A51P, CYP3A43 | Cyp3a11, Cyp3a13, Cyp3a16, Cyp3a25, Cyp3a41a, Cyp3a41b, Cyp3a44, Cyp3a57, Cyp3a59 | Alliance of Genome Resources | ||||
| B-lymphoblastic leukemia/lymphoma | TFPI* | Tfpi | Alliance of Genome Resources | ||||
| B-lymphoblastic leukemia/lymphoma | TNFSF13* | Tnfsf13 | Alliance of Genome Resources | ||||
| B-lymphoblastic leukemia/lymphoma | TP53* | Trp53 | Alliance of Genome Resources | ||||
| B-lymphoblastic leukemia/lymphoma | F3* | F3 | Alliance of Genome Resources | ||||
| B-lymphoblastic leukemia/lymphoma | IKZF1* | Ikzf1 | Alliance of Genome Resources | ||||
| B-lymphoblastic leukemia/lymphoma | ABL1* | Abl1 | Alliance of Genome Resources | ||||
| Burkitt lymphoma | CALR* | Calr | Alliance of Genome Resources | ||||
| Burkitt lymphoma | CD79B* | Cd79b | Alliance of Genome Resources | ||||
| Burkitt lymphoma | CD40* | Cd40 | Alliance of Genome Resources | ||||
| Burkitt lymphoma | BTK* | Btk | Alliance of Genome Resources | ||||
| central nervous system lymphoma | IL10* | Il10 | Alliance of Genome Resources | ||||
| central nervous system lymphoma | MYD88* | Myd88 | Alliance of Genome Resources | ||||
| central nervous system lymphoma | BTK* | Btk | Alliance of Genome Resources | ||||
| central nervous system lymphoma | CD79B* | Cd79b | Alliance of Genome Resources | ||||
| childhood acute lymphocytic leukemia | TES* | Tes, Tesl1 | Alliance of Genome Resources | ||||
| chronic lymphocytic leukemia | PON1* | Pon1 | Alliance of Genome Resources | ||||
| chronic lymphocytic leukemia | CD79B* | Cd79b | Alliance of Genome Resources | ||||
| chronic lymphocytic leukemia | CD86* | Cd86 | Alliance of Genome Resources | ||||
| chronic lymphocytic leukemia | IRF4* | Irf4 | Alliance of Genome Resources | ||||
| chronic lymphocytic leukemia | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | ABCG2* | Abcg2, Abcg3 | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | ABCB1* | Abcb1a, Abcb1b | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | ABCC2* | Abcc2 | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | ABL1* | Abl1 | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | AKT1* | Akt1 | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | BCL2L1* | Bcl2l1 | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | BCR* | Bcr | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | CRKL* | Crkl | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | CYP3A5*, CYP3A4, CYP3A7, CYP3A7-CYP3A51P, CYP3A43 | Cyp3a11, Cyp3a13, Cyp3a16, Cyp3a25, Cyp3a41a, Cyp3a41b, Cyp3a44, Cyp3a57, Cyp3a59 | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | FAS* | Fas | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | FASLG* | Fasl | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | IL10* | Il10 | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | MDM2* | Mdm2 | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | NQO1* | Nqo1 | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
| chronic myeloid leukemia | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
| chronic myelomonocytic leukemia | ASXL1* | Asxl1 | Alliance of Genome Resources | ||||
| chronic myelomonocytic leukemia | CDKN2B*, CDKN2A | Cdkn2a, Cdkn2b | Alliance of Genome Resources | ||||
| chronic myelomonocytic leukemia | CSF3R* | Csf3r | Alliance of Genome Resources | ||||
| chronic myelomonocytic leukemia | EZH2* | Ezh2 | Alliance of Genome Resources | ||||
| chronic myelomonocytic leukemia | TET2* | Tet2 | Alliance of Genome Resources | ||||
| chronic neutrophilic leukemia | CSF3R* | Csf3r | Alliance of Genome Resources | ||||
| diffuse large B-cell lymphoma | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| diffuse large B-cell lymphoma | IL21R* | Il21r | Alliance of Genome Resources | ||||
| diffuse large B-cell lymphoma | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| diffuse large B-cell lymphoma | GSTP1* | Gstp1, Gstp2, Gstp3 | Alliance of Genome Resources | ||||
| diffuse large B-cell lymphoma | FCGR2A*, FCGR2B, FCGR2C | Fcgr2b, Fcgr3 | Alliance of Genome Resources | ||||
| diffuse large B-cell lymphoma | MYD88* | Myd88 | Alliance of Genome Resources | ||||
| diffuse large B-cell lymphoma | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| diffuse large B-cell lymphoma | CD79B* | Cd79b | Alliance of Genome Resources | ||||
| diffuse large B-cell lymphoma | CD40* | Cd40 | Alliance of Genome Resources | ||||
| diffuse large B-cell lymphoma | CD22* | Cd22 | Alliance of Genome Resources | ||||
| diffuse large B-cell lymphoma | CARD11* | Card11 | Alliance of Genome Resources | ||||
| diffuse large B-cell lymphoma | BCL6* | Bcl6 | Alliance of Genome Resources | ||||
| essential thrombocythemia | SH2B3* | Sh2b3 | Alliance of Genome Resources | ||||
| essential thrombocythemia | VWF* | Vwf | Alliance of Genome Resources | ||||
| essential thrombocythemia | THPO* | Thpo | Alliance of Genome Resources | ||||
| essential thrombocythemia | CALR* | Calr | Alliance of Genome Resources | ||||
| essential thrombocythemia | MPL* | Mpl | Alliance of Genome Resources | ||||
| extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue | BIRC3* | Birc3 | Alliance of Genome Resources | ||||
| extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
| extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue | BCL10* | Bcl10 | Alliance of Genome Resources | ||||
| follicular lymphoma | CD40LG* | Cd40lg | Alliance of Genome Resources | ||||
| follicular lymphoma | KDSR* | Kdsr | Alliance of Genome Resources | ||||
| follicular lymphoma | CD79B* | Cd79b | Alliance of Genome Resources | ||||
| follicular lymphoma | CD40* | Cd40 | Alliance of Genome Resources | ||||
| follicular lymphoma | BCL2* | Bcl2 | Alliance of Genome Resources | ||||
| hairy cell leukemia | GPX1* | Gpx1 | Alliance of Genome Resources | ||||
| hematologic cancer | SLC19A1* | Slc19a1 | Alliance of Genome Resources | ||||
| hematologic cancer | TP53* | Trp53 | Alliance of Genome Resources | ||||
| Hodgkin's lymphoma | KLHDC8B* | Klhdc8b | Alliance of Genome Resources | ||||
| Hodgkin's lymphoma | NFKBIA* | Nfkbia | Alliance of Genome Resources | ||||
| Hodgkin's lymphoma | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| Hodgkin's lymphoma | IL6* | Il6 | Alliance of Genome Resources | ||||
| Hodgkin's lymphoma | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| juvenile myelomonocytic leukemia | AKAP12* | Akap12 | Alliance of Genome Resources | ||||
| juvenile myelomonocytic leukemia | ARHGAP26* | Arhgap26 | Alliance of Genome Resources | ||||
| juvenile myelomonocytic leukemia | CBL* | Cbl | Alliance of Genome Resources | ||||
| juvenile myelomonocytic leukemia | CSF2* | Csf2 | Alliance of Genome Resources | ||||
| juvenile myelomonocytic leukemia | JAK3* | Jak3 | Alliance of Genome Resources | ||||
| leukemia | NAT2*, NAT1 | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
| leukemia | BCR* | Bcr | Alliance of Genome Resources | ||||
| leukemia | AKR1C3*, AKR1C1, AKR1C2, AKR1C4 | Akr1c6, Akr1c12, Akr1c13, Akr1c14, Akr1c18, Akr1c19, Akr1c20, Akr1c21, Akr1cl | Alliance of Genome Resources | ||||
| leukemia | JAK2* | Jak2 | Alliance of Genome Resources | ||||
| leukemia | ACSL6* | Acsl6 | Alliance of Genome Resources | ||||
| leukemia | GPX1* | Gpx1 | Alliance of Genome Resources | ||||
| leukemia | ACE* | Ace | Alliance of Genome Resources | ||||
| leukemia | ETV6* | Etv6 | Alliance of Genome Resources | ||||
| leukemia | FADD* | Fadd | Alliance of Genome Resources | ||||
| leukemia | CDKN2A*, CDKN2B | Cdkn2a, Cdkn2b | Alliance of Genome Resources | ||||
| leukemia | ABO* | Abo | Alliance of Genome Resources | ||||
| leukemia | NQO1* | Nqo1 | Alliance of Genome Resources | ||||
| leukemia | PDGFRA* | Pdgfra | Alliance of Genome Resources | ||||
| lymphoid leukemia | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| lymphoid leukemia | GSTP1* | Gstp1, Gstp2, Gstp3 | Alliance of Genome Resources | ||||
| lymphoid leukemia | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| lymphoid leukemia | FCGR2A*, FCGR2B*, FCGR2C | Fcgr2b, Fcgr3 | Alliance of Genome Resources | ||||
| lymphoid leukemia | ETV6* | Etv6 | Alliance of Genome Resources | ||||
| lymphoid leukemia | BCL2L1* | Bcl2l1 | Alliance of Genome Resources | ||||
| lymphoma | PAFAH1B2* | Pafah1b2 | Alliance of Genome Resources | ||||
| lymphoma | PSMB9* | Psmb9 | Alliance of Genome Resources | ||||
| lymphoma | MALT1* | Malt1 | Alliance of Genome Resources | ||||
| lymphoma | RELA* | Rela | Alliance of Genome Resources | ||||
| lymphoma | CHD4* | Chd4 | Alliance of Genome Resources | ||||
| lymphoma | MAD1L1* | Mad1l1 | Alliance of Genome Resources | ||||
| lymphoplasmacytic lymphoma | FCGR3A*, FCGR3B | Fcgr4 | Alliance of Genome Resources | ||||
| lymphoplasmacytic lymphoma | MYD88* | Myd88 | Alliance of Genome Resources | ||||
| lymphoplasmacytic lymphoma | IL10* | Il10 | Alliance of Genome Resources | ||||
| lymphoplasmacytic lymphoma | IL6* | Il6 | Alliance of Genome Resources | ||||
| lymphoplasmacytic lymphoma | CXCR4* | Cxcr4 | Alliance of Genome Resources | ||||
| mantle cell lymphoma | BTK* | Btk | Alliance of Genome Resources | ||||
| mantle cell lymphoma | CCDC50* | Ccdc50 | Alliance of Genome Resources | ||||
| mantle cell lymphoma | CD79B* | Cd79b | Alliance of Genome Resources | ||||
| mantle cell lymphoma | TNFRSF10A*, TNFRSF10B, TNFRSF10C, TNFRSF10D | Tnfrsf10b | Alliance of Genome Resources | ||||
| marginal zone lymphoma | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| marginal zone lymphoma | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
| mature T-cell and NK-cell lymphoma | H19* | H19 | Alliance of Genome Resources | ||||
| multiple myeloma | MIR320A* | Mir320 | Alliance of Genome Resources | ||||
| multiple myeloma | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| multiple myeloma | MTR* | Mtr | Alliance of Genome Resources | ||||
| multiple myeloma | MTRR* | Mtrr | Alliance of Genome Resources | ||||
| multiple myeloma | NFKBIA* | Nfkbia | Alliance of Genome Resources | ||||
| multiple myeloma | NQO1* | Nqo1 | Alliance of Genome Resources | ||||
| multiple myeloma | NRAS* | Nras | Alliance of Genome Resources | ||||
| multiple myeloma | PF4*, PF4V1 | Pf4 | Alliance of Genome Resources | ||||
| multiple myeloma | POLR1G* | Polr1g | Alliance of Genome Resources | ||||
| multiple myeloma | PON1* | Pon1 | Alliance of Genome Resources | ||||
| multiple myeloma | RBP1* | Rbp1 | Alliance of Genome Resources | ||||
| multiple myeloma | ROBO1* | Robo1 | Alliance of Genome Resources | ||||
| multiple myeloma | SOD2* | Sod2 | Alliance of Genome Resources | ||||
| multiple myeloma | SPARC* | Sparc | Alliance of Genome Resources | ||||
| multiple myeloma | SPP1* | Spp1 | Alliance of Genome Resources | ||||
| multiple myeloma | TFRC* | Tfrc | Alliance of Genome Resources | ||||
| multiple myeloma | TGFB1* | Tgfb1 | Alliance of Genome Resources | ||||
| multiple myeloma | TNF* | Tnf | Alliance of Genome Resources | ||||
| multiple myeloma | TNFRSF10A*, TNFRSF10B, TNFRSF10C, TNFRSF10D | Tnfrsf10b | Alliance of Genome Resources | ||||
| multiple myeloma | TNFRSF17* | Tnfrsf17 | Alliance of Genome Resources | ||||
| multiple myeloma | TP53* | Trp53 | Alliance of Genome Resources | ||||
| multiple myeloma | TYMS* | Tyms | Alliance of Genome Resources | ||||
| multiple myeloma | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
| multiple myeloma | XPO5* | Xpo5 | Alliance of Genome Resources | ||||
| multiple myeloma | XRCC3* | Xrcc3 | Alliance of Genome Resources | ||||
| multiple myeloma | XRCC4* | Xrcc4 | Alliance of Genome Resources | ||||
| multiple myeloma | XRCC5* | Xrcc5 | Alliance of Genome Resources | ||||
| multiple myeloma | ABCG2* | Abcg2, Abcg3 | Alliance of Genome Resources | ||||
| multiple myeloma | ACE* | Ace | Alliance of Genome Resources | ||||
| multiple myeloma | APOE* | Apoe | Alliance of Genome Resources | ||||
| multiple myeloma | BCL2L10* | Bcl2l10 | Alliance of Genome Resources | ||||
| multiple myeloma | CBX7* | Cbx7 | Alliance of Genome Resources | ||||
| multiple myeloma | CCND1* | Ccnd1 | Alliance of Genome Resources | ||||
| multiple myeloma | CD40* | Cd40 | Alliance of Genome Resources | ||||
| multiple myeloma | CD40LG* | Cd40lg | Alliance of Genome Resources | ||||
| multiple myeloma | CFHR1*, CFHR2 | Cfhr1 | Alliance of Genome Resources | ||||
| multiple myeloma | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
| multiple myeloma | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
| multiple myeloma | CYP2C19*, CYP2C8, CYP2C9, CYP2C18 | Cyp2c29, Cyp2c37, Cyp2c38, Cyp2c39, Cyp2c40, Cyp2c50, Cyp2c54, Cyp2c55, Cyp2c65, Cyp2c66, Cyp2c67, Cyp2c68, Cyp2c69 | Alliance of Genome Resources | ||||
| multiple myeloma | EPHX1* | Ephx1 | Alliance of Genome Resources | ||||
| multiple myeloma | ERCC1* | Ercc1 | Alliance of Genome Resources | ||||
| multiple myeloma | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
| multiple myeloma | FCGR2A*, FCGR2B, FCGR2C | Fcgr2b, Fcgr3 | Alliance of Genome Resources | ||||
| multiple myeloma | FGG* | Fgg | Alliance of Genome Resources | ||||
| multiple myeloma | GPX1* | Gpx1 | Alliance of Genome Resources | ||||
| multiple myeloma | CDKN2A*, CDKN2B | Cdkn2a, Cdkn2b | Alliance of Genome Resources | ||||
| multiple myeloma | GPX3* | Gpx3 | Alliance of Genome Resources | ||||
| multiple myeloma | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| multiple myeloma | GSTP1* | Gstp1, Gstp2, Gstp3 | Alliance of Genome Resources | ||||
| multiple myeloma | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| multiple myeloma | HFE* | Hfe | Alliance of Genome Resources | ||||
| multiple myeloma | HK1* | Hk1 | Alliance of Genome Resources | ||||
| multiple myeloma | ICAM1* | Icam1 | Alliance of Genome Resources | ||||
| multiple myeloma | IL1A* | Il1a | Alliance of Genome Resources | ||||
| multiple myeloma | IL1B* | Il1b | Alliance of Genome Resources | ||||
| multiple myeloma | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
| multiple myeloma | IL4R* | Il4ra | Alliance of Genome Resources | ||||
| multiple myeloma | IL10* | Il10 | Alliance of Genome Resources | ||||
| multiple myeloma | IRF4* | Irf4 | Alliance of Genome Resources | ||||
| multiple myeloma | IRF8* | Irf8 | Alliance of Genome Resources | ||||
| multiple myeloma | KRAS* | Kras | Alliance of Genome Resources | ||||
| multiple myeloma | LIG4* | Lig4 | Alliance of Genome Resources | ||||
| multiple myeloma | MEFV* | Mefv | Alliance of Genome Resources | ||||
| multiple myeloma | MET* | Met | Alliance of Genome Resources | ||||
| mycosis fungoides | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | CSF3R* | Csf3r | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | CDKN2A*, CDKN2B* | Cdkn2a, Cdkn2b | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | CDKN1B* | Cdkn1b | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | BCL2L10* | Bcl2l10 | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | ARPC1B* | Arpc1b | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | FCGR3A*, FCGR3B | Fcgr4 | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | GATA2* | Gata2 | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | GNB1* | Gnb1 | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | GSTP1* | Gstp1, Gstp2, Gstp3 | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | HFE* | Hfe | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | IDH1* | Idh1 | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | MEFV* | Mefv | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | MTRR* | Mtrr | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | NRAS* | Nras | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | PLCB1* | Plcb1 | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | TET2* | Tet2 | 1 model | Alliance of Genome Resources | |||
| myelodysplastic syndrome | TP53* | Trp53 | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | ZFPM2* | Zfpm2 | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | ZRSR2*, ZRSR2P1 | Zrsr2, Zrsr2-ps1 | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | DNMT3A* | Dnmt3a | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | EZH2* | Ezh2 | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | ETV6* | Etv6 | Alliance of Genome Resources | ||||
| myelodysplastic syndrome | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
| myelofibrosis | CALR* | Calr | Alliance of Genome Resources | ||||
| myelofibrosis | KMT2A* | Kmt2a | Alliance of Genome Resources | ||||
| myelofibrosis | ASXL1* | Asxl1 | Alliance of Genome Resources | ||||
| myelofibrosis | MPL* | Mpl | Alliance of Genome Resources | ||||
| myelofibrosis | HFE* | Hfe | Alliance of Genome Resources | ||||
| myelofibrosis | EZH2* | Ezh2 | Alliance of Genome Resources | ||||
| myelofibrosis | SH2B3* | Sh2b3 | Alliance of Genome Resources | ||||
| myeloid leukemia | ERG* | Erg | Alliance of Genome Resources | ||||
| myeloid leukemia | PDGFRA* | Pdgfra | Alliance of Genome Resources | ||||
| myeloid leukemia | UGT1A1* | Ugt1a1 | Alliance of Genome Resources | ||||
| myeloid leukemia | GATA2* | Gata2 | Alliance of Genome Resources | ||||
| myeloid leukemia | PRAME*, PRAMEF1, PRAMEF2, PRAMEF4, PRAMEF5, PRAMEF6, PRAMEF7, PRAMEF8, PRAMEF10, PRAMEF11, PRAMEF12, PRAMEF13, PRAMEF14, PRAMEF15, PRAMEF17, PRAMEF18, PRAMEF19, PRAMEF20, PRAMEF22, PRAMEF25, PRAMEF26, PRAMEF27, PRAMEF33 | Gm13040, Gm13043, Pramel5, Pramel11, Pramel12, Pramel13, Pramel15, Pramel16, Pramel19, Pramel20, Pramel21, Pramel24, Pramel28, Pramel30, Pramel31, Pramel32, Pramel34, Pramel35, Pramel36, Pramel37, Pramel38, Pramel40, Pramel41, Pramel42, Pramel43, Pramel44, Pramel46, Pramel47, Pramel48, Pramel49, Pramel50, Pramel53, Pramel54, Pramel55, Pramel56, Pramel57, Pramel60, Pramel61 | Alliance of Genome Resources | ||||
| myeloid leukemia | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| myeloid leukemia | GSTP1* | Gstp1, Gstp2, Gstp3 | Alliance of Genome Resources | ||||
| myeloid leukemia | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| myeloid leukemia | IFNG* | Ifng | Alliance of Genome Resources | ||||
| myeloid leukemia | FGFR1* | Fgfr1 | Alliance of Genome Resources | ||||
| myeloid leukemia | NSD3* | Nsd3 | Alliance of Genome Resources | ||||
| myeloid leukemia | MN1* | Mn1 | Alliance of Genome Resources | ||||
| myeloid leukemia | CBX7* | Cbx7 | Alliance of Genome Resources | ||||
| myeloid leukemia associated with Down Syndrome | GATA1* | Gata1 | Alliance of Genome Resources | ||||
| myeloid neoplasm | JAK2* | Jak2 | Alliance of Genome Resources | ||||
| myeloid neoplasm | ETV6* | Etv6 | Alliance of Genome Resources | ||||
| myeloid neoplasm | FGFR1* | Fgfr1 | Alliance of Genome Resources | ||||
| myeloid neoplasm | GPX1* | Gpx1 | Alliance of Genome Resources | ||||
| myeloid neoplasm | CBL* | Cbl | Alliance of Genome Resources | ||||
| myeloid neoplasm | MECOM* | Mecom | Alliance of Genome Resources | ||||
| myeloid neoplasm | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| myeloid sarcoma | KRAS* | Kras | Alliance of Genome Resources | ||||
| myeloid sarcoma | PDGFRA* | Pdgfra | Alliance of Genome Resources | ||||
| myeloproliferative neoplasm | DDX41* | Ddx41 | Alliance of Genome Resources | ||||
| myeloproliferative neoplasm | TET2* | Tet2 | Alliance of Genome Resources | ||||
| myeloproliferative neoplasm | ETV6* | Etv6 | Alliance of Genome Resources | ||||
| nasal type extranodal NK/T-cell lymphoma | FAS* | Fas | Alliance of Genome Resources | ||||
| non-Hodgkin lymphoma | RAD54B* | Rad54b | Alliance of Genome Resources | ||||
| non-Hodgkin lymphoma | TMEM260* | Tmem260 | Alliance of Genome Resources | ||||
| non-Hodgkin lymphoma | CD40* | Cd40 | Alliance of Genome Resources | ||||
| non-Hodgkin lymphoma | CCND1* | Ccnd1 | Alliance of Genome Resources | ||||
| non-Hodgkin lymphoma | CASP10* | ||||||
| non-Hodgkin lymphoma | BCL10* | Bcl10 | Alliance of Genome Resources | ||||
| non-Hodgkin lymphoma | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
| non-Hodgkin lymphoma | CD79B* | Cd79b | Alliance of Genome Resources | ||||
| non-Hodgkin lymphoma | EPHX1* | Ephx1 | Alliance of Genome Resources | ||||
| non-Hodgkin lymphoma | FCGR2A*, FCGR2B, FCGR2C | Fcgr2b, Fcgr3 | Alliance of Genome Resources | ||||
| non-Hodgkin lymphoma | GPX1* | Gpx1 | Alliance of Genome Resources | ||||
| non-Hodgkin lymphoma | KMT2A* | Kmt2a | Alliance of Genome Resources | ||||
| non-Hodgkin lymphoma | MALT1* | Malt1 | Alliance of Genome Resources | ||||
| non-Hodgkin lymphoma | MTRR* | Mtrr | Alliance of Genome Resources | ||||
| non-Hodgkin lymphoma | PON1* | Pon1 | Alliance of Genome Resources | ||||
| non-Hodgkin lymphoma | PRF1* | Prf1 | Alliance of Genome Resources | ||||
| non-Hodgkin lymphoma | RAD54L* | Rad54l | Alliance of Genome Resources | ||||
| peripheral T-cell lymphoma | IRF4* | Irf4 | Alliance of Genome Resources | ||||
| plasma cell leukemia | CD40* | Cd40 | Alliance of Genome Resources | ||||
| plasmacytoma | BCL2* | Bcl2 | Alliance of Genome Resources | ||||
| plasmacytoma | ROBO1* | Robo1 | Alliance of Genome Resources | ||||
| polycythemia vera | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| polycythemia vera | HFE* | Hfe | Alliance of Genome Resources | ||||
| primary cutaneous T-cell non-Hodgkin lymphoma | CDKN2A*, CDKN2B* | Cdkn2a, Cdkn2b | Alliance of Genome Resources | ||||
| T-cell acute lymphoblastic leukemia | CDKN2A*, CDKN2B | Cdkn2a, Cdkn2b | Alliance of Genome Resources | ||||
| T-cell acute lymphoblastic leukemia | AKR1C3*, AKR1C1, AKR1C2, AKR1C4 | Akr1c6, Akr1c12, Akr1c13, Akr1c14, Akr1c18, Akr1c19, Akr1c20, Akr1c21, Akr1cl | Alliance of Genome Resources | ||||
| T-cell acute lymphoblastic leukemia | RPL5* | Rpl5 | Alliance of Genome Resources | ||||
| T-cell acute lymphoblastic leukemia | PDGFRA* | Pdgfra | Alliance of Genome Resources | ||||
| T-cell acute lymphoblastic leukemia | LYL1* | Lyl1 | Alliance of Genome Resources | ||||
| T-cell acute lymphoblastic leukemia | NUP98* | Nup98 | Alliance of Genome Resources | ||||
| T-cell acute lymphoblastic leukemia | JAK3* | Jak3 | Alliance of Genome Resources | ||||
| T-cell acute lymphoblastic leukemia | JAK1* | Jak1 | Alliance of Genome Resources | ||||
| T-cell acute lymphoblastic leukemia | DNMT3A* | Dnmt3a | Alliance of Genome Resources | ||||
| T-cell acute lymphoblastic leukemia | CXCR4* | Cxcr4 | Alliance of Genome Resources | ||||
| T-cell acute lymphoblastic leukemia | RPL11* | Rpl11 | Alliance of Genome Resources | ||||
| T-cell non-Hodgkin lymphoma | TMEM260* | Tmem260 | Alliance of Genome Resources | ||||
| T-cell non-Hodgkin lymphoma | IER3* | Ier3 | Alliance of Genome Resources | ||||
| T-cell non-Hodgkin lymphoma | FGFR1* | Fgfr1 | Alliance of Genome Resources | ||||
| T-cell non-Hodgkin lymphoma | JAK3* | Jak3 | Alliance of Genome Resources | ||||
| T-cell prolymphocytic leukemia | JAK3* | Jak3 | Alliance of Genome Resources | ||||
| testicular lymphoma | MYD88* | Myd88 | Alliance of Genome Resources | ||||
| transient myeloproliferative syndrome | GATA1* | Gata1 | 2 models | Alliance of Genome Resources | |||
Excel File
|
Transgenes and other genome features developed in mice to model this disease.
|
|||
| Disease Term | Transgenes and Other Genome Features | Mouse Models | |
| acute leukemia | Tg(Ly6a-SET/NUP214)2969Gcg | 1 model | |
| acute lymphoblastic leukemia | Tg(Lck-Notch3)#Issc | 1 model | |
| acute lymphoblastic leukemia | Tg(Igh-HMGA2)#Cro | 1 model | |
| acute lymphoblastic leukemia | Tg(CD2-Lmo2)#Thr | 1 model | |
| acute myeloid leukemia | Tg(Vav1-ERG)#Jpim | 1 model | |
| acute myeloid leukemia | Tg(Vav1-Asxl1*Y588X)#Fcy | 1 model | |
| acute myeloid leukemia | Tg(CMV-SALL4_iB)#Chai | 1 model | |
| acute promyelocytic leukemia | Tg(CTSG-NUMA1/RARA)#Skr | 1 model | |
| acute promyelocytic leukemia | Tg(PML-RARA)556Kog | 2 models | |
| Burkitt lymphoma | Tg(IGL-MYC)3Hm | 1 model | |
| Burkitt lymphoma | Tg(IghMyc)22Bri | 1 model | |
| chronic lymphocytic leukemia | Tg(Lck-TNFSF13)3919Mhah | 1 model | |
| chronic lymphocytic leukemia | Tg(Igh-V186.2-TCL1A)3Cro | 4 models | |
| chronic lymphocytic leukemia | Tg(Igh-TCL1A)1Ypek | 1 model | |
| chronic lymphocytic leukemia | Tg(Igh-ROR1)1Kip | 2 models | |
| chronic lymphocytic leukemia | Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro | 2 models | |
| chronic lymphocytic leukemia | Mirc30 | 6 models | |
| chronic lymphocytic leukemia | Del(14Trim13-Rnaseh2b)6Rdf | 2 models | |
| chronic lymphocytic leukemia | Del(14Trim13-Dleu2)4Rdf | 2 models | |
| chronic myeloid leukemia | Tg(tetO-BCR/ABL1)2Dgt | 2 models | |
| chronic myeloid leukemia | Tg(Ly6a-TK,-BCR/ABL1)IS9AIsg | 1 model | |
| chronic myeloid leukemia | Tg(Ly6a-BCR/ABL1)IS1BIsg | 1 model | |
| chronic myeloid leukemia | Tg(Ly6a-BCR/ABL1)IS1AIsg | 1 model | |
| essential thrombocythemia | Tg(JAK2*V617F)FF1Rsko | 1 model | |
| essential thrombocythemia | Tg(Vav1-JAK2*V617F)AZjz | 1 model | |
| extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue | Tg(Ly6e-MALT1)#Isg | 1 model | |
| follicular lymphoma | Tg(Vav-BCL2)69Jad | 1 model | |
| leukemia | Tg(Vav1-STAT5B*N642H)726Biat | 1 model | |
| lymphoid leukemia | Tg(Lck-Tal1)4709Led | 1 model | |
| lymphoma | Tg(H2-K-Hmga1)#Lmsr | 1 model | |
| lymphoma | Tg(Vav1-STAT5B*N642H)726Biat | 1 model | |
| multiple myeloma | Tg(Cd4-NPM/ALK)N1Ingh | 1 model | |
| multiple myeloma | Tg(Igh-Maf)68Staka | 1 model | |
| multiple myeloma | Tg(Igh-Maf)524Staka | 1 model | |
| multiple myeloma | Tg(Igkv3-5*-MYC)24Plbe | 1 model | |
| myelodysplastic syndrome | Tg(CMV-SALL4_iB)#Chai | 1 model | |
| myelodysplastic syndrome | Tg(Vav1-Asxl1*Y588X)#Fcy | 1 model | |
| myelodysplastic syndrome | Tg(Vav1-NUP98/HOXD13)C1Apla | 1 model | |
| myelodysplastic syndrome | Tg(Vav1-NUP98/HOXD13)G2Apla | 1 model | |
| myelofibrosis | Tg(H2-Kb-Jak2*V617F)2Shmd | 1 model | |
| myelofibrosis | Tg(Vav1-JAK2*V617F)AZjz | 1 model | |
| myeloproliferative neoplasm | Tg(Vav1-Asxl1*Y588X)#Fcy | 1 model | |
| non-Hodgkin lymphoma | Tg(EmuSR-HDAC9)1468Kpet | 1 model | |
| non-Hodgkin lymphoma | Tg(tetO-NPM1/ALK,-luc)2Gde | 1 model | |
| non-Hodgkin lymphoma | Tg(tetO-TPM3/ALK,-luc)2Gde | 1 model | |
| plasmacytoma | Tg(H2-L-IL6)46Kish | 1 model | |
| polycythemia vera | Tg(Vav1-JAK2*V617F)AZjz | 1 model | |
| polycythemia vera | Tg(JAK2*V617F)FF1Rsko | 1 model | |
| T-cell acute lymphoblastic leukemia | Tg(H2-K-Hmga1)#Lmsr | 1 model | |
| T-cell adult acute lymphocytic leukemia | Tg(Lck-Tax)53Hall | 1 model | |